Search
for
Sort by
Research 121–150 of 386
- Toward a Diagnostic Score in Cushing's Syndrome
- Chemoprevention of smoke-induced alopecia in mice by oral administration of l-cystine and vitamin B6
- Acquired scalp alopecia. Part II: A review
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Treatment options for alopecia: an update, looking to the future
- Adult epidermal Notch activity induces dermal accumulation of T cells and neural crest derivatives through upregulation of jagged 1
- Treatment strategies for alopecia
- Hidradenitis Suppurativa
- Cicatricial alopecia
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Primary Scarring Alopecia: Clinical-Pathological Review of 72 Cases and Review of the Literature
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Effect of <i>Ficus carica</i> leaf extract on the gene expression of selected factors in HaCaT cells
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- What′s new in cicatricial alopecia?
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Lucio Phenomenon: Sequelae of Neglected Leprosy
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Drug eruptions in dermatology
- Guía clínica chilena para el estudio y tratamiento de hidradenitis supurativa. Resumen ejecutivo
- LC–MS bioanalytical method for simultaneous determination of latanoprost and minoxidil in the skin
- Metabolism and skin diseases
- New Treatments for Hair Loss
- Endocrine disorders and hormonal therapy for adolescent acne
- The Association Between Hidradenitis Suppurativa and Diet: An Update.
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists